Jaguar Health, Inc. (JAGX)
NASDAQ·Healthcare·Biotechnology
$0.39
-6.01%
Mkt Cap $2.05M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$3.21
Range $3.21 – $3.21
Implied Upside
+723.5%
Consensus $3.21 vs current $0.39
NASDAQ·Healthcare·Biotechnology
$0.39
-6.01%
Mkt Cap $2.05M
No recent rating data.
Price Target (2 analysts)
$3.21
Range $3.21 – $3.21
+723.5%
Consensus $3.21 vs current $0.39